“…A recent systematic review determined that exercise-based CR is associated with a lower risk of both overall mortality (relative risk, 0.87; 95% confidence interval [CI], 0.75Y0.99) and cardiovascular mortality (relative risk, 0.74; 95% CI, 0.63Y0.87) in patients up to 12 months after an ACS. 13 Compared with usual care, exercisebased CR can also reduce risk factors contributing to progression of ACS through greater reductions in total cholesterol (weighted mean difference [WMD], j0.37 mmol/L; 95% CI, j0.63 to j0.11 mmol/L), triglyceride levels (WMD, j0.23 mmol/L; 95% CI, j0.39 to j0.07 mmol/L), systolic blood pressure (WMD, j3.2 mm Hg; 95% CI, j5.4 to j0.9 mm Hg), and lower rates of self-reported smoking (odds ratio, 0.64; 95% CI, 0.50Y0.83). 14 These effects are independent of mode of CR delivery.…”